Live Pilot Study updates | Page 2

Live Pilot Study news coverage of developments with the latest updates. Stay on top of latest Pilot Study news stories and find out what just happened, what is going on with Pilot Study. The latest real-time news updates and headlines on Pilot Study
Minns Advocates More Student Housing, Not Fewer Students
Amivantamab-Chemo Yields Best Survival in EGFR NSCLC
Zidesamtinib Shows 93% Response in ROS1-positive NSCLC
Eight-Year ADAURA Update: Osimertinib Boosts Survival
Trastuzumab Deruxtecan Boosts Survival in HER2 Lung Cancer
Australia's First Human Milk Biobank: Every Drop Counts
KAIST, KIOM Unveil Wearable Microneedle For Pain Relief
Costly Phosphate? Homegrown Fertilizer Solution
WA Farm Confidence Rebounds, Season Key Factor
Research Finds Low Overdiagnosis In Breast Cancer Screening
Tasmanian Farmers Cautiously Optimistic About Season Ahead
Winter Rain Tops Up SA Rural Confidence
Victorian Farm Sector Confidence Rebounds, Outlook Steady
Polluted Air Linked to Increased Glaucoma, Cataract Risk
Ancestral Practices Aid Healing Across Generations
NSW Farmer Confidence Up, Cost Pressures Still Loom
Australian Farmer Confidence Stages Recovery
AI Tool Speeds Sepsis Detection on World Sepsis Day
Algorithm Off, Misogyny Persists in Manosphere
Hidden Rhythms Drive Heart Rate Dynamics
Snail Shells Are Surprise Weather Time Capsules
Smartphones May Screen for Cataracts, Eye Issues
Perth CBD Gains 174 New Social, Affordable Rentals
KAIST, KIOM Create Wearable Pain-Relief Device
Winston Peters - "Cool Heads, Rational Judgement"
MAVERICK Trial Backs Brain MRI Alone for Lung Cancer
Phase III TAISHAN-302: Tam-Peli Boosts Survival in SCLC
ARTEMIS-008: Risvutatug Boosts Survival in Lung Cancer
Sacituzumab, Pembrolizumab Combo Misses NSCLC Targets
NSW Sepsis Day Unveils New AI Tool for Faster Detection
Perception Test Predicts Laser Surgery Success
9/11 Memories May Be Faulty: 25-Year Study Reveals
Pumitamig Plus Elfetabart Shows Promise in Lung Cancer
Tarlatamab Dosing Shows Promise in Small Cell Lung Cancer
Therapy Fails to Boost Survival After Dual Immunotherapy
Phase 1 Backs Phase 3 Dose for Lung Cancer Drug
Atezolizumab Combo Doubles Event-Free Survival in NSCLC
Subcutaneous Tarlatamab Safe, Effective in SCLC Trial
Sheffield Cracks UK's Top 15 in 2027 Guardian Guide
Bacteria Colonies Spread Swiftly Through Fluid Flow
More Specialist Care For Babies In Melbourne's West
Strict Blood Sugar Control May Lower Life Enjoyment
UNC Unveils Tool to Identify High-Risk Cancer Periods
CU Anschutz Advances Precision Medicine for Rare Cancers
New Disease Causes Night Blindness, Vision Loss
Rare Neurons Found: Key to Inducing Brain Sleep
Selfie Culture to Food Science: 7 Unique U of T Courses
Battling Poverty Now Secures Future Generations